282 related articles for article (PubMed ID: 9931087)
1. Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
Ribstein J; Halimi JM; du Cailar G; Mimran A
Hypertension; 1999 Jan; 33(1):90-5. PubMed ID: 9931087
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral contraceptives on the renin angiotensin system and renal function.
Kang AK; Duncan JA; Cattran DC; Floras JS; Lai V; Scholey JW; Miller JA
Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R807-13. PubMed ID: 11171661
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
4. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
Wu JN; Tsai SY; Hsieh WY
Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.
Ahmed SB; Hovind P; Parving HH; Rossing P; Price DA; Laffel LM; Lansang MC; Stevanovic R; Fisher ND; Hollenberg NK
Diabetes Care; 2005 Aug; 28(8):1988-94. PubMed ID: 16043743
[TBL] [Abstract][Full Text] [Related]
7. Effects of converting enzyme inhibition on split renal function in renovascular hypertension.
Miyamori I; Yasuhara S; Takeda Y; Koshida H; Ikeda M; Nagai K; Okamoto H; Morise T; Takeda R; Aburano T
Hypertension; 1986 May; 8(5):415-21. PubMed ID: 3009326
[TBL] [Abstract][Full Text] [Related]
8. The effect of captopril on renal hemodynamics in hypertensive patients.
Duchin KL; Willard DA
J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
[TBL] [Abstract][Full Text] [Related]
9. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin-converting enzyme inhibition on altered renal hemodynamics induced by low protein diet in the rat.
Fernández-Repollet E; Tapia E; Martínez-Maldonado M
J Clin Invest; 1987 Oct; 80(4):1045-9. PubMed ID: 3308957
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
Hall JE; Granger JP
Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
[TBL] [Abstract][Full Text] [Related]
14. The effect of oral contraceptives on the nitric oxide system and renal function.
Cherney DZ; Scholey JW; Cattran DC; Kang AK; Zimpelmann J; Kennedy C; Lai V; Burns KD; Miller JA
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1539-44. PubMed ID: 17715260
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
Reams GP; Lau A; Knaus V; Bauer JH
J Clin Pharmacol; 1993 Apr; 33(4):348-53. PubMed ID: 8473550
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
17. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
[TBL] [Abstract][Full Text] [Related]
18. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
[TBL] [Abstract][Full Text] [Related]
19. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
Hollenberg NK
Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
[TBL] [Abstract][Full Text] [Related]
20. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
